OPEN END TURBO LONG - JOHNSON & JOHNSON Share Price

Certificat

DE000MD8WUR9

Real-time Bid/Ask 12:58:34 28/06/2024 BST
1.83 EUR / 1.86 EUR +0.82% Intraday chart for OPEN END TURBO LONG - JOHNSON & JOHNSON
Current month-6.63%
1 month-12.44%
Date Price Change
28/06/24 1.84 +0.55%
27/06/24 1.83 -6.15%
26/06/24 1.95 0.00%
25/06/24 1.95 -10.14%
24/06/24 2.17 +2.36%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:42 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer Morgan Stanley
WKN MD8WUR
ISINDE000MD8WUR9
Date issued 03/10/2022
Strike 126.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.35
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.33
Lowest since issue 1.75
Spread 0.02
Spread %1.08%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.8 USD
Average target price
171.7 USD
Spread / Average Target
+17.78%
Consensus